In mouse models of ovarian cancer, PD-1 blockade plus OX40 stimulation has a synergistic effect in enhancing the infiltration of effector immune cells and inducing a tumor-specific T cell response, demonstrating the feasibility of combining OX40 with other checkpoints75. Here, PDCD1 is linked to ovarian carcinoma.